Quadrant Capital Group LLC
- SEC CIK
- 0001650717
- Latest filing
- Aug 14, 2026
RLAY holding history
Relay Therapeutics, Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RLAY overviewAll 13F holders of RLAYFull Q2 2026 holdings
- Shares (Q2 2026)
- 11,791
- Value
- $220.6K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 11,791 | $220.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 11,791 | $117.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 11,791 | $99.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 11,791 | $61.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 11,791 | $40.8K | <0.1% | +8,374+245.1% | Added | Holders |
| Q1 2025 | 3,417 | $8.95K | <0.1% | +2,972+667.9% | Added | Holders |
| Q4 2024 | 445 | $1.83K | <0.1% | +394+772.5% | Added | Holders |
| Q3 2024 | 51 | $362 | <0.1% | −1,045−95.3% | Reduced | Holders |
| Q2 2024 | 1,096 | $7.15K | <0.1% | +1,096 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −72−100.0% | Sold out | Holders |
| Q4 2022 | 72 | $1.08K | <0.1% | +72 | New | Holders |